Eversept Partners »

Beta Bionics shares owned by Eversept Partners

Quarter-by-quarter ownership of Beta Bionics (BBNX) shares owned by Eversept Partners from 13F filings

Historical chart of Eversept Partners investment in Beta Bionics

Tip: Access up to 7 years of quarterly data

All positions including Beta Bionics held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beta Bionics by Eversept Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $21M 678k 30.47

More positions owned by Eversept Partners

Vera Therapeutics Cl A (VERA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
GSK Sponsored Adr (GSK)
United Therapeutics Corporation (UTHR)
Abivax Sa Sponsored Ads (ABVX)
Natera (NTRA)
Syndax Pharmaceuticals (SNDX)
Miragen Therapeutics (VRDN)
Vaxcyte (PCVX)
Travere Therapeutics (TVTX)
Hca Holdings (HCA)
Danaher Corporation (DHR)
Ionis Pharmaceuticals (IONS)
Celldex Therapeutics Com New (CLDX)
Bruker Corporation (BRKR)

View all positions for Eversept Partners

Top funds holding Beta Bionics

Eventide Asset Management
Farallon Capital Management
Wellington Management Company
Sands Capital Ventures
BlackRock
Soleus Capital Management
Rtw Investments
Vanguard Group
Healthcare Of Ontario Pension Plan Trust Fund
Omega Fund Management
Driehaus Capital Management
Point72 Asset Management
Deerfield Management Company
Geode Capital Management
State Street Corporation

View all funds holding Beta Bionics